1. Phase I, dose-escalation study of the investigational drug D07001-F4, an oral formulation of gemcitabine HCl, in patients (pts) with advanced solid tumors or lymphoma. (December 2016) Authors: Lin, C.C.; Su, W.C.; Chao, Y.; Lee, J.H.; Hsu, C.H.; Cheng, A.L.; Chung, W.P.; Chen, M.H.; Lin, C.L.; Ho, H.L.; Huang, L.P.; Huang, C.T.; Hsueh, S.P.; Yang, J.C.H. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗